Page last updated: 2024-10-27

gabexate and Mycoplasma dispar Infection

gabexate has been researched along with Mycoplasma dispar Infection in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"A case of acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection was treated in an 8-year-old girl."1.35Continuous regional arterial infusion therapy for acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection in a child. ( Hara, M; Nakagawa, M; Ogino, H; Shibamoto, Y; Shimohira, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakagawa, M1
Ogino, H1
Shimohira, M1
Hara, M1
Shibamoto, Y1

Other Studies

1 other study available for gabexate and Mycoplasma dispar Infection

ArticleYear
Continuous regional arterial infusion therapy for acute necrotizing pancreatitis due to Mycoplasma pneumoniae infection in a child.
    Cardiovascular and interventional radiology, 2009, Volume: 32, Issue:3

    Topics: Anti-Bacterial Agents; Child; Contrast Media; Drug Therapy, Combination; Female; Gabexate; Humans; I

2009